J of Cosmetic Dermatology 2024 Vachiramon Microfocused Ultrasound
J of Cosmetic Dermatology 2024 Vachiramon Microfocused Ultrasound
1Division of Dermatology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand | 2Private Practice for Dermatology &
Aesthetics, Munich, Germany | 3Ocean Clinic Marbella, Málaga, Spain | 4 Skin Research Institute & Skin Associates of South Florida, Coral Gables,
Florida, USA | 5Lenox Hill Hospital and Manhattan Eye, Ear, and Throat Hospital, New York, New York, USA | 6Apkoo-Jung Oracle Dermatology Clinic,
Seoul, Republic of Korea | 7Julieta Spada Dermatology & Aesthetics, Buenos Aires, Argentina | 8Dermatology Private Office, São Paulo, Brazil | 9Global
Medical Affairs, Merz Aesthetics, Raleigh, North Carolina, USA
Funding: This work was supported by Merz Aesthetics Global Medical Affairs.
Keywords: energy-based devices | MFU-V | microfocused ultrasound with visualization | regenerative aesthetics | Ultherapy
ABSTRACT
Background: Microfocused ultrasound with visualization (MFU-V) is widely used in aesthetic medicine for skin tightening and
rejuvenation. However, its role in regenerative aesthetics and its precise mechanism of action are not fully understood.
Objective: This narrative review aims to contextualize and articulate the mechanism of action of MFU-V, evaluate its role in
regenerative aesthetics, and assess its effectiveness based on existing clinical, histological, and skin-mechanical studies.
Methods: A comprehensive literature search was performed to collect and analyze studies on MFU's biological mechanisms,
clinical outcomes, and impact on extracellular matrix (ECM) regeneration. The review integrates findings from clinical trials,
histological analyses, and biomechanical assessments to provide a cohesive understanding of MFU-V 's role in aesthetic medicine.
Results: MFU-V emits focused ultrasound energy that penetrates multiple skin layers and the superficial musculoaponeurotic
system, creating localized thermal coagulation points. These points initiate biological responses that recruit fibroblasts and stim-
ulate the production of new collagen and elastin fibers. Enhanced ECM protein synthesis leads to significant improvements in
skin biomechanics and quality, reducing skin laxity and enhancing appearance. Clinical studies support these findings, showing
improvements in skin firmness and texture following MFU-V treatment.
Conclusion: Through analyzing the underlying biological mechanisms and the observable clinical outcomes, this narrative re-
view sets the stage for a comprehensive understanding of the mechanism of action and role of MFU-V in regenerative aesthetics.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is
properly cited.
© 2024 The Author(s). Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.
FIGURE 1 | MFU-V transducers targeting various skin layers (SMAS, reticular/papillary dermis) at specific depths (4.5 mm, 3.0 mm, 1.5 mm),
demonstrating precise depth-controlled thermal coagulation. DS, DeepSee.
3 of 22
14732165, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jocd.16658 by CAPES, Wiley Online Library on [27/12/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
TABLE 1 | Transducer setting and associated energy levels in Joules (J).
FIGURE 2 | MFU-V 's mechanism of action for skin regeneration. (A) Three phases: Inflammation (TCP triggers immune response), Proliferation
(fibroblasts produce new collagen/elastin), and Remodeling (collagen/elastin mature, restructuring skin). (B) Conceptual timeline and illustrative
relative intensity of biological processes over 100 days. The y-a xis represents qualitative intensity.
elastin regeneration processes. The MFU-V process is marked cells by binding pattern recognition receptors to stimulate tem-
by TCPs, which are discrete, consistent in size, and optimally porary inflammatory pathways. This is followed by the release
spaced when compared to those produced by other HIFU de- of cytokines and chemokines, which attract numerous cell
vices [13]. types, including macrophages, involved in the healing process
[41, 42]. In a 2024 animal study, skin tissue around TCPs was
excised following the application of energy levels 2 and 4 at
4.3 | Temporary Immune Response depths of 1.5, 3.0-, and 4.5-mm [38]. Histological analysis in-
dicated the TCPs consisted of collagen, which exhibited a loss
The inflammatory portion of the body's healing response is ini- of its fine fibrillar structure, indicative of denaturation. From
tiated by damage-associated molecular patterns (DAMPs) that Day 14 to Day 90, there were observable changes in TCP size,
are released by affected tissue. These signals activate immune cellular activity, and collagen maturity. Although the presence
Denaturation
Kist et al. n/s In vivo study Immediate, 3 n/s Healthy n/s n/s Pre-auricular region Thermacool Multiple pass, Multiple low-
2006 [13] with 3 subjects 24 h, and 6 m device low-energy RF energy passes (97 J)
treatment (varying increased collagen
Joules and passes) damage similar to
versus single single high-energy
pass, high-energy (166 J) pass, with
RF treatment 50% collagen
replacement in
6 months, enhancing
skin tightening
White et al. USA In vivo study No follow-up 6 cadavers 33% n/a 49–72 years Mixed Superficial Ulthera Ultrasound Intense ultrasound
2007 [40] on cadaveric female musculoaponeurotic (Ultherapy), therapy to create therapy created
facial tissue (2/6) system (SMAS) Intense thermal injury thermal injury
Ultrasound zones in the zones up to
System SMAS layer 7.8 mm deep in the
SMAS layer, with
precise targeting
and minimal
surrounding
tissue damage
Marquardt Germany, Non-clinical 14 and n/a n/a Yucatan n/s n/a Face and Ulthera Microfocused Inflammation was
et al. 2024 [38] USA study on 90 days Miniature subcutaneous (MFU-V, Merz ultrasound mild and transient
histological Swine models tissue (SMAS) Aesthetics) targeting depths following treatment;
evolution of 1.5, 3.0, and Demonstrates
of TCPs 4.5 mm, TCP elastin neogenesis
post-M FU-V formation, and neocollagenesis
treatment collagen after MFU-V
remodeling, and treatment;
elastin neogenesis significant fibroblast
recruitment to
the TCP areas
Suh et al. South Prospective 2m 11 90.9% Patients with 35–64 years Asian Face and neck Doublo Intense focused Increased collagen
2015 [39] Korea study with female facial skin laxity (HIRONIC Co.) ultrasound fibers without signs
histologic (10/11) (IFUS) for facial of inflammation
evaluation tightening; two or fat necrosis;
handpieces with increased fibrosis
3 and 4.5 mm between fat
focal depths layers confirmed
histologically
(Continues)
5 of 22
14732165, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jocd.16658 by CAPES, Wiley Online Library on [27/12/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
TABLE 2 | (Continued)
6 of 22
Study characteristics Participants characteristics Exposure/intervention Outcomes
Vachiramon Thailand Prospective, 56 days 13 92.3% Healthy subjects, Mean age Fitzpatrick Abdomen (filler Ulthera (MFU), MFU performed HA degradation
et al. 2023 pilot study on female HA filler 37.8 years skin types injection sites) Belotero on the same observed when
[43] combined HA recipients III-V Balance HA day, day 14, and MFU performed
filler and MFU filler (Merz day 28 after HA within 14 days
treatments Aesthetics) filler injection, post-H A injection;
histological no significant
analysis of HA histological changes
loss at different after 28 days; no
intervals inflammatory
reactions or
granuloma
Casabona Brazil Clinical and 180 days 1 100% Healthy subject 45 years n/s Inner thighs and Ulthera (MFU- MFU-V combined Neocollagenesis and
et al. 2014 histological female undergoing inner retroauricular area V), Radiesse with Radiesse neoelastogenesis
[44] study thigh surgery (CaHA) and hyaluronic after combined
acid fillers treatment; filler
safety with MFU-V
Keagle et al. USA Animal study 1, 2, 5, 14, 3 rodents n/a Healthy n/a n/a Dermis and epidermis n/a Wounding Heat shock proteins
2001 [45] on linear rodent and 28 days followed by (HSPs) Hsp 47, 72,
wound healing expression 32 expression in
analysis of heat wound healing;
shock proteins collagen synthesis
involvement
Hantash et al. USA Prospective, 10 weeks n/s n/s Healthy n/a n/a Dermis Renesis System Bipolar fractional Induction of
2009 [46] histological (bipolar RF treatment neocollagenesis and
study fractional RF) neoelastogenesis,
dermal remodeling,
collagen
replacement
Ishida et al. Japan Review article n/a n/a n/a n/a n/a n/a n/a n/a Molecular Collagen
2011 [47] chaperone HSP47 maturation,
interaction molecular
with collagen chaperones
Proliferation
(Continues)
Marquardt Germany, Non-clinical 14 and n/a n/a Yucatan n/s n/a Face and Ulthera Microfocused Inflammation was
et al. 2024 [38] USA study on 90 days Miniature subcutaneous (MFU-V, Merz ultrasound mild and transient
histological Swine models tissue (SMAS) Aesthetics) targeting depths following treatment;
evolution of 1.5, 3.0, and demonstrates elastin
of TCPs 4.5 mm, TCP neogenesis and
post-M FU-V formation, neocollagenesis after
treatment collagen MFU-V treatment;
remodeling, and significant fibroblast
elastin neogenesis recruitment to
the TCP areas
White et al. USA In vivo study No follow-up 6 cadavers 33% n/a 49–72 years Mixed Superficial Ulthera Ultrasound Selective thermal
2007 [40] on cadaveric female musculoaponeurotic (Ultherapy), therapy to create injury targeting
facial tissue (2/6) system (SMAS) Intense thermal injury SMAS for
Ultrasound zones in the noninvasive facial
System SMAS layer rejuvenation,
thermal collagen
denaturation
Marquardt Germany, Non-clinical 14 and n/a n/a Yucatan n/s n/a Face and Ulthera Microfocused Inflammation was
et al. 2024 [38] USA study on 90 days Miniature subcutaneous (MFU-V, Merz ultrasound mild and transient
histological Swine models tissue (SMAS) Aesthetics) targeting depths following treatment;
evolution of 1.5, 3.0, and demonstrates elastin
of TCPs 4.5 mm, TCP neogenesis and
post-M FU-V formation, neocollagenesis after
treatment collagen MFU-V treatment;
remodeling, and significant fibroblast
elastin neogenesis recruitment to
the TCP areas
Suh et al. South Prospective 2m 11 90.9% Facial laxity 35–64 years Asian Face and neck Doublo Intense focused Increased collagen
2015 [39] Korea study, histologic female (HIRONIC Co.) ultrasound with fibers without signs
evaluation 3.0 and 4.5 mm of inflammation
transducers, or fat necrosis;
multiple passes increased fibrosis
per treated area between fat
layers confirmed
histologically
Laubach et al. USA In vitro study n/a n/a n/a Postmortem skin n/a n/s Dermis Ulthera Inc. Intense focused Thermal
2008 [48] on postmortem prototype ultrasound (IFUS) damage, collagen
skin samples device for precise thermal denaturation
coagulation
(Continues)
7 of 22
14732165, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jocd.16658 by CAPES, Wiley Online Library on [27/12/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
TABLE 2 | (Continued)
8 of 22
Study characteristics Participants characteristics Exposure/intervention Outcomes
Gliklich et al. USA Open-label, Immediate 15 60% Patients Mean n/s Face, neck Prototype Intense ultrasound Evaluation of
2007 [49] phase 1 study (within 24 h) scheduled for 53 years device (Ulthera therapy to deep clinical safety,
and delayed rhytidectomy (SD ± 7) Inc.) dermal facial skin histologic
(4–12 weeks) and subcutaneous features, pain, and
tissues inflammation
Suh et al. South Prospective 2m 22 90.9% Facial laxity Mean age Fitzpatrick Nasolabial fold, Ulthera (IFUS) Intense focused Improvement
2011 [50] Korea study, histologic female 48.5 years types jawline ultrasound for in nasolabial
analysis III–VI facial tightening, folds and jawline
histologic laxity; increased
evaluation dermal collagen
of collagen and straighter
production elastic fibers in
reticular dermis
Suh et al. South Prospective 2–3 m 10 100% Periorbital 45–73 years Fitzpatrick Periorbital Ulthera System Intense focused Moderate to good
2019 [51] Korea study, histologic female wrinkles types (crow's feet) (Ulthera Inc.) ultrasound improvement in
analysis III-I V using 1.5 mm periorbital wrinkles;
transducer, increased collagen
targeting fine and and elastic fiber
deep wrinkles in density, minimal
periorbital area side effects (welts,
erythema)
Yutskovskaya Russia Randomized, 15 m 20 100% Age-related 35–45 years n/s Lower face, neck, Ulthera (MFU- Combination of Improvement
et al. 2020 split-face skin laxity décolleté, abdomen V) + Radiesse diluted CaHA in age-related
[52] comparative (CaHA diluted) and MFU-V; changes, high
clinical study increased collagen patient satisfaction;
and elastin histological
fibers, enhanced evaluation of
neocollagenesis, collagen I/III, Ki67,
and skin angiogenesis
remodeling
Suh et al. South Prospective, 6m 15 86.67% Infraorbital laxity 27–69 years Fitzpatrick Lower eyelid Ulthera System Intense-focused Improved
2012 [53] Korea clinical study female types III–V (infraorbital laxity) (Ulthera Inc.) ultrasound for infraorbital
on infraorbital infraorbital laxity, increased
laxity treatment laxity, applied collagen and elastic
with a 7.0 MHz, fiber density;
3.0 mm focal minimal side
depth transducer effects (erythema,
edema, purpura)
(Continues)
Lin 2020 [54] Australia Prospective, 3 and 6 m 21 100% Postpartum 25–40 years Mostly Lower abdomen Ulthera System MFU-V using 1.5-, Significant
clinical study female lower abdominal Asian, (postpartum (Ulthera Inc.) 3.0-, and 4.5-mm improvement in skin
on postpartum skin laxity some skin laxity) transducers, 1140 laxity, increased
lower Caucasian lines total across collagen and fibrous
abdominal lower abdomen septae thickness,
laxity no significant
adverse events, high
patient satisfaction
at 6 months
Vachiramon Thailand Randomized, 1, 3, and 30 (28 100% Abdominal Mean age Fitzpatrick Abdomen (single- Ulthera System MFU-V with Significant
et al. 2020 prospective, 6 m post- completed) female skin laxity 43.3 years skin type and dual-plane) (Ulthera, Inc.) 4.5 and 3.0 mm reduction in waist
[55] comparative treatment III transducers circumference
study on (single and dual- for childbirth
abdominal plane treatment patients, comparable
skin laxity for abdominal improvement for
skin laxity) both protocols, pain
scores recorded,
transient erythema,
and edema
Meyer et al. Brazil, Experimental 45 and 30 100% Patients with 30–60 years Mixed Full face Heros HIFU Single MFU Clinical
2021 [56] USA, study on the 90 days post- female facial skin aging (Fismatek) session using 1.5, improvement in
Chile effects of treatment (tissue laxity, 3, and 4.5 mm facial symmetry,
MFU on facial wrinkles) transducers, increased collagen
rejuvenation energy ranging type I, improved
from 0.1 to 2.0 J firmness and
wrinkle reduction;
transient hyperemia
and pain during
treatment
Sasaki et al. USA Prospective, 6 weeks 2 100% Healthy subjects, 30–65 years n/s Pre-auricular Ultherapy Dual density Increased Type I and
2021 [57] single-center, female scheduled for region (face) (MFU-V; MFU-V (30 lines Type III collagen
single-blinded, rhytidectomy Merz North using 7–3.0 mm synthesis (26% and
nonrandomized America, Inc.) transducer, 60% increases,
study on 30 lines using respectively); no
collagen 4–4.5 mm adverse events;
synthesis transducer) heavy water method
post-M FU-V to measure in vivo
collagen synthes
(Continues)
9 of 22
14732165, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jocd.16658 by CAPES, Wiley Online Library on [27/12/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
TABLE 2 | (Continued)
10 of 22
Follow-up No. partici Sex Health status/ Device
Author, year Country Design period pants (%F) characteristics Age Ethnicity Treated sites (Brand) Treatment Categories
Casabona Spain Case study of 6m 1 100% Healthy 60-year- 60 years n/s Face (pre- Ultherapy MFU-V combined Increased dermal
et al. 2023 a combined female old patient auricular areas) (MFU-V ), with calcium and epidermal
[58] collagen undergoing Radiesse hydroxylapatite- thickness,
stimulation facelift surgery (Ca-H A filler), based filler and most effective
procedure Belotero Revive hyaluronic acid in combined
(HA filler), filler, along with treatments; collagen
Dermapen microneedling organization
microneedling improved; enhanced
neocollagenesis
in SMAS and
retinacula cutis
Vachiramon Thailand Prospective, 56 days 13 92.3% Healthy subjects, Mean age Fitzpatrick Abdomen (filler Ulthera (MFU), MFU performed HA degradation
et al. 2023 pilot study on female HA filler 37.8 years skin types injection sites) Belotero on the same observed when
[43] combined HA recipients III–V Balance HA day, day 14, and MFU performed
filler and MFU filler (Merz day 28 after HA within 14 days
treatments Aesthetics) filler injection, post-H A injection;
histological no significant
analysis of HA histological changes
loss at different after 28 days; no
intervals inflammatory
reactions or
granuloma
Marquardt Germany, Non-clinical 14 and n/a n/a Yucatan n/s n/a Face and Ulthera Microfocused Inflammation was
et al. 2024 [38] USA study on 90 days Miniature subcutaneous (MFU-V, Merz ultrasound mild and transient
histological Swine models tissue (SMAS) Aesthetics) targeting depths following treatment;
evolution of 1.5, 3.0, and demonstrates elastin
of TCPs 4.5 mm, TCP neogenesis and
post-M FU-V formation, neocollagenesis after
treatment collagen MFU-V treatment;
remodeling, and significant fibroblast
elastin neogenesis recruitment to
the TCP areas
White et al. USA In vivo study No follow-up 6 cadavers 33% n/a (cadaveric) 49–72 years Mixed Superficial Ulthera Ultrasound Selective thermal
2007 [40] on cadaveric (cadaveric female musculoaponeurotic (Ultherapy), therapy to create injury targeting
facial tissue study) (2/6) system (SMAS) Intense thermal injury SMAS for
Ultrasound zones in the noninvasive facial
System SMAS layer rejuvenation,
thermal collagen
denaturation
of macrophages and giant cells were noted, no inflammation III is converted into collagen type I. The creation of TCPs via
was seen at 90 days. These findings were supported by a clin- targeted application of MFU-V energy causes localized protein
ical trial that collected 11 tissue samples from patients after a denaturing at the dermal planes [40, 48, 49]. This induces pro-
single MFU-V treatment at the 4.5 mm depth and 4.4 MHz fre- tein regeneration and ECM restructuring via healing processes
quency, revealing no epidermal changes or inflammatory reac- to resemble a youthful-associated ECM environment. Clinical
tions at 2 months [39]. Additionally, Vachiramon et al. found studies utilizing qualitative and quantitative measures of skin
no inflammation at Day 56 in a clinical trial of 14 subjects quality and physiological function lend scientific support to the
studying the treatment combination of MFU-V and hyaluronic reasoning that dermal restructuring occurs through the regen-
acid (CPM-H A 22.5 mg/mL, Belotero Balance, Merz Aesthetics, eration and reorganization of proteins and key components.
Raleigh, NC, USA) [43]. Studies of the face, neck, and lower abdomen have shown struc-
tural ECM recovery at the microanatomical level [50–52].
Animal tissue analyzed through H&E staining showed cells, in-
cluding fibroblasts, macrophages, T-cells, and a small number Histological analysis from Suh et al. on skin biopsies taken
of giant cells, infiltrating and accumulating around the edges from the lateral cheek of 11 MFU-V-treated female patients be-
of the TCP at 14 days. By 90 days, these cells had significantly fore treatment and 2 months prior showed a 23.7% (p < 0.001)
infiltrated the TCP [38]. increase from baseline in collagen at the reticular dermis,
with dermal mean thickness increasing from 1.32 to 1.63 mm
(+65.9%, p < 0.001) supporting neocollagenesis. Elastin fibers
4.4 | Proliferation were found straighter and more parallel following treatment,
suggesting MFU-V-induced reorganization to a more youthful
The healing process requires a balance of protein degradation state [50]. Performing a similar histological analysis of biopsies
and synthesis. Throughout the proliferative phase of the heal- from 11 patient cheeks 2 months after MFU non-v isual treat-
ing process, matrix metalloproteinases (MMPs) expressed by ment with a specified 4 MHz, 4.5 mm probe at an energy level of
fibroblasts and macrophages degrade denatured proteins to be 1.2 J, Suh et al. visualized increased collagen density of the retic-
replaced with granulation tissue consisting of immature collagen, ular dermis [39]. In a 2019 study of a single MFU-V treatment to
fibronectin, and proteoglycans. Granulation tissue forms a scaf- the periorbital region with a 19 MHz, 1.5 mm probe at an energy
fold for the cells involved in the healing process to migrate and level of 0.15–0.25 J, Suh et al. obtained three patients before-
differentiate, promoting mature tissue deposition [41]. Heat shock and-after biopsies at 2 to 3 months post-treatment. While the
proteins (HSPs) also play a role during collagen and elastin regen- histometric assessment was non-significant, collagen density
eration in response to EBD treatment [44–46]. The collagen chap- increased by 28.22% in the upper papillary dermis and 14.95%
erone, Hsp47, assists in collagen replacement at TCP sites [47]. in the lower reticular dermis. The elastic fiber was reported to
Marquardt et al. found a higher number of Hsp47-positive cells increase by 23.59% and 33.04% in the papillary and reticular der-
in the tissue surrounding the TCP at 14 days, with 85.0% of cells mis layers, respectively [51]. From Suh et al., two subjects receiv-
being Hsp47-positive but remaining on the border of the TCP. At ing a single treatment of MFU-V had punch biopsies from their
90 days, 98.9% of the cells were Hsp47 positive and in significantly lower eyelids, with significant loss of collagen and elastic fibers
higher concentrations within the TCP than in the surrounding tis- before treatment and showing regeneration of collagen and elas-
sue indicating infiltration leading to proliferation [38]. tic fibers 6 months post-treatment [53]. In addition, the elastin-
positive area in the TCPs of swine tissue at 14 days, compared to
90 days, was strongly increased [38].
4.5 | ECM Rejuvenation via Remodeling
In a study treating lower abdomen laxity postpartum, Lin ap-
Maturation, or remodeling, is the final step in the healing pro- plied MFU-V within 6 months of childbirth using three stan-
cess. Mature elastin and collagen are formed, and collagen type dard transducers with variable frequency and focal depth to
11 of 22
14732165, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jocd.16658 by CAPES, Wiley Online Library on [27/12/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
target specific anatomical layers of the anterior abdominal wall thickness. These findings underline the potential of MFU-V
[54]. A single patient sample recovered from lower abdomino- as a noninvasive option for skin rejuvenation, offering sig-
plasty 6 weeks post-M FU-V treatment showed a significant nificant improvements in skin quality and structure, thereby
increase in total collagen in both the dermis and subcutane- contributing to the broader goals of aesthetic and therapeutic
ous tissue of pretreated samples compared to controls with dermatology.
standard microscopy at 10× magnification, with further ex-
amination at 40× revealing denser and larger collagen bun-
dles. Additionally, deeper analysis demonstrated an increase 5 | Improved Skin Physiological Function
in the number and thickness of fibrous septae within the ad-
ipose layer between the dermis and Scarpa's fascia. However, In regenerative aesthetics, it is crucial to recover structural ECM
adipocyte sizes in superficial and deeper fat compartments re- proteins and quantify improved skin function. For instance, “re-
mained unchanged. These septae are thought to contribute to generative” treatments should stimulate enough collagen to no-
the smoothness/tautness of the skin surface. Despite a short ticeably enhance skin firmness [1]. Various functional aspects
interval and limited sample size, Lin and Suh et al. targeted the of skin are pertinent in aesthetics, each linked to specific ECM
fascia and connecting fibrous septae at the SMAS and appeared proteins. These include but are not limited to skin firmness (col-
to contribute to improved skin quality with MFU treatment. A lagen), elasticity (elastin), hydration (proteoglycans), and oxy-
similar finding was demonstrated by Vachiramon et al., with genation (angiogenesis) [10].
both single-(4.5 mm) and dual-plane (4.5 and 3.0 mm) having
similar effectiveness in treating abdominal skin laxity, partic- A noticeable manifestation of physical aging includes changes in
ularly in patients who had undergone childbirth [55]. In addi- skin biomechanics. When cells age and ECM protein production
tion to neocollagenesis and protein fiber reorganization, Meyer slows, the mechanical implications include decreased firmness
et al. demonstrated significant changes within a three-patient and elasticity, which contribute to increasing wrinkle severity
histological sample collected 45 days following a single MFU and skin laxity [59, 60]. Thus, validating regenerative aesthetic
treatment across facial regions. A substantial rise in collagen treatments requires measuring structural regeneration and
type I compared to type III was seen, along with significant skin mechanics. The Cutometer is a widely used, clinically vali-
increases in fibroblasts (p = 0.02) blood vessels (p = 0.0062), dated, noninvasive tool to measure skin biomechanics. It applies
suggesting angiogenesis in dermal remodeling and inflamma- suction to the skin and measures its resistance to deformation
tory cells (p = 0.0036). Immunohistochemistry confirmed the (firmness) and elastic recoil (elasticity) [61, 62]. In Cutometer
presence of the CD68 macrophage marker, IHQ, indicating measurements, R2 and R5 assess skin elasticity. R2, known as
phagocytosis of necrotic adipose tissue and matched with fi- “gross elasticity,” measures the skin's overall elasticity [63]. On
brosis associated with increased fibroblast activity and colla- the other hand, R5, known as “net elasticity,” also measures the
gen synthesis [56]. Sasaki et al. conducted a case series of two skin's elastic recovery after being stretched. Using cutometry,
subjects involving a split-face MFU-V treatment on one side of Kerscher et al. conducted a 22-patient study that evaluated the
the face in the pre-auricular region and no treatment on the short and long-term impact of a single MFU-V targeting pre-
other side as the control [57]. The treatment included a triple- selected depths of 4.5 and 3.0 mm on skin biomechanics [64].
depth, high density, 30 lines of treatment per transducer in- Short-term results indicated no significant reductions in skin
volving the following transducers and energy levels/frequency: temperature, erythema, hydration, or barrier function. The re-
4 MHz, 4.5 mm (0.90 J), 7 MHz, 3.0 mm (0.30 J), and 10 MHz, sults showed a significant decrease in R2 and R5 values 4 weeks
1.5 mm (0.18 J). At 1 month, collagen synthesis increased 8.4% post-treatment, suggesting a physiological restructuring of col-
for Collagen I and 16.8% for Collagen III compared to the tis- lagen tissue. However, both elasticity parameters significantly
sue on the control side. Collagen I synthesis increased by 26% increased at 12-and 24-week post-treatment, indicating an im-
on average, and Collagen III increased by 60% on the treated provement in skin firmness. This pattern of initial reduction
side of the two subjects' faces compared to baseline. In a sin- followed by improvement in elasticity aligns with the expected
gle patient case study undergoing sub-SMAS facelift surgery, outcomes of collagen and elastin remodeling induced by MFU-V
histological analysis from Casabona et al. on a tissue sample treatment [64].
of monotherapy MFU-V saw a modest improvement in SMAS
thickness with a slight improvement in skin thickness overall A 22-patient split-face study by Lee et al. evaluated the differ-
and parallel organization of collagen fibers [58]. ences in pore size and skin biomechanics following a single
treatment using the 10-MHz 1.5 mm on one side of the face and
The emerging research surrounding MFU and MFU-V treat- the 7-MHz 3.0 mm transducer on the other. When assessing R2
ments highlights a promising advancement in dermatolog- (gross elasticity), R5 (net elasticity), and R7 (biological elasticity)
ical therapy by focusing on the rejuvenation and structural using a Cutometer, it was found that within the first 3 weeks,
refinement of the dermal ECM. Studies have consistently R2, R5, and R7 were most improved with a 1.5 mm transducer.
demonstrated that targeted MFU- V energy can effectively However, 6 months post-treatment, skin treated with a 3.0 mm
induce a regenerative process in the skin, leading to the re- transducer had significantly higher elastic values across all
structuring of critical ECM components, primarily collagen three R measures. This suggests that a multiple, deeper-depth
and elastin. This enhances the skin's mechanical properties treatment holds advantages over a single-depth superficial treat-
and functional integrity and replicates a more youthful ECM ment in restoring skin elasticity [65]. These results suggest that
architecture. The histological evidence from various studies an initial thermal degradation of collagen is followed by colla-
supports the efficacy of MFU-V in promoting neocollagenesis, gen and elastin synthesis, resulting in improved skin firmness
reorganizing elastin fibers, and increasing skin turgidity and and elasticity relative to baseline, highlighting the advantages
13 of 22
TABLE 3 | Combination uses of MFU-V and other aesthetic procedures.
14 of 22
Reference Study type treated Adjunctive therapy Location ethnicity Outcome
Aksenenko, 2019 Controlled, comparative study Facial aging Fractional CO2 laser Russia 47–55 years, 100% Skin density increased by
[77] female, n/s 22.5% (combined group) versus
13% (control); recovery time
reduced from 22 to 10 days
Barbarino, 2021 [87] Case series Tear trough HA filler (Belotero USA, 35–65 years, 100% Physicians rated 90% “very
deformities balance) Netherlands, female, n/s much improved” after combined
Australia treatment versus 0% initially; all
10 participants very satisfied
Bartsch et al., 2020 Randomized interventional Skin laxity & CaHA filler (Radiesse), Austria, Spain, 37.2 ± 6.8 years, Showed the highest improvement
[88] prospective study dimpling tissue stabilized guided USA, Germany, 100% female, n/s in skin laxity (2.23 odds)
subcision (Cellfina) Philippines and dimpling (1.79 odds)
Bozkurt & Tatar, Case report Burn scars Fractional CO2 laser, Turkey 18 years, 100% Reduced burn scar hardness,
2021 [89] nanofat injections female, n/s swelling, and itching in two sessions
Carruthers et al., Consensus Aesthetic HA (Belotero) and USA, Canada n/s, mixed, n/s Expert consensus recommends
2016 [90] correction CaHA (Radiesse) fillers using MFU-V before injectable
agents like BoNT and fillers for
optimal facial rejuvenation
Casabona & Objective, nonrandomized Stretch marks Dilute CaHA (Radiesse), Brazil 21–34 years, 100% Significantly improved stretch marks,
Marchese, 2017 [91] study microneedling, and female, n/s decreasing scar scores by 4.9 points.
ascorbic acid
Casabona & Histological Aesthetic HA filler (Juvederm Brazil 45 years, 100% Enhanced collagen and
Michalany, 2014 collagen loss Voluma), CaHA female, n/s elastin production without
[44] filler (Radiesse) causing granulomas or
altering filler properties
Casabona & Pereira, Retrospective; histological Skin laxity CaHA filler (Radiesse) Brazil 18–55 years, 100% Significantly improved cellulite
2017 [92] and cellulite female, n/s severity in 90 days, with a 4.5-
point CSS improvement
Casabona & Retrospective Skin laxity and CaHA filler (Radiesse) Brazil 35–55 years, 100% Improved neck and décolletage lines
Teixeira, 2018 [93] lines of the neck female, n/s by at least one grade in 90 days
& décolletage
(Continues)
(Continues)
15 of 22
14732165, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jocd.16658 by CAPES, Wiley Online Library on [27/12/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
TABLE 3 | (Continued)
16 of 22
Reference Study type treated Adjunctive therapy Location ethnicity Outcome
Hart et al., 2015 [71] Case series Aging of the PLLA (Sculptra) USA n/s, n/a, n/s Efficiently improved face, neck,
face, neck, and and décolletage rejuvenation with
décolletage reduced downtime in one session
Jeon et al., 2018 Prospective, evaluator- Horizontal BONT-A South Korea 24–50 years, 100% Significantly reduced neck wrinkle
[100] blinded study neck lines (IncobotulinumtoxinA), female, Asian length by 59% in 6 months
HA filler (Belotero),
CaHA filler (Radiesse)
Jerdan & Fabi, 2016 Expert opinion Aging face PLLA (Sculptra), USA n/a, n/a, not Effectively tightened off-face
[73] IPL, NIR specified areas like neck, chest, and thighs,
showing significant improvement
in skin laxity and wrinkles
Kwon et al., 2018 Randomized interventional Facial laxity TPIG South Korea 39–69 years, 100% Histologic analysis confirmed
[79] prospective study female, Fitzpatrick increased dermal collagen fibers
skin type III and IV post-treatment, indicating enhanced
skin tightening and lifting efficacy
Kwon et al., 2018 Prospective, evaluator- Facial laxity MPRF (Thermage South Korea 39–69 years, 100% 90% of patients showing moderate
[79] blinded study CPT System) female, Fitzpatrick to marked improvement in facial
skin type III and IV skin laxity after 20 weeks
Park et al., 2020 Prospective, evaluator- Periocular HA filler (Belotero South Korea 24–58 years, 100% Improved eyebrow height by 3.9 mm,
[101] blinded study rejuvenation Balance, Belotero female, Asian showing significant periocular
Soft), BONT-A rejuvenation in 12 weeks
(IncobotulinumtoxinA)
Park et al., 2023 [80] Retrospective Enlarged BONT-A South Korea 36.9 ± 5.5 years, Reduced facial pore count by 62%
facial pores (IncobotulinumtoxinA) 95% female, Asian in 6 months, showing sustained
improvement without rebound
Ramirez & Puah, Prospective, single-arm Brachial CaHA filler (Radiesse) Singapore 35–65 years, 100% Improved brachial skin laxity,
2021 [102] skin laxity female, 25% Asian, increasing skin firmness by 16% in
75% Caucasian 24 weeks, with high satisfaction
Salomao et al., 2016 Case report Facial Erbium-YAG laser, Brazil 35–65 years, 100% Significantly improved skin
[76] photoageing radiofrequency female, n/s laxity and wrinkles in 40 days
microneedle
(Continues)
17 of 22
14732165, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jocd.16658 by CAPES, Wiley Online Library on [27/12/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
14732165, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jocd.16658 by CAPES, Wiley Online Library on [27/12/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
erythema with mild scabbing (moderate) and mild edema MFU-V has also shown promise in combination with other
and welts (mild) [82]. The most frequently reported adverse treatments, such CaHA and HA fillers, potentially enhancing
event in the majority of studies was mild to moderate pain. outcomes through a synergistic approach. However, more rigor-
Pain levels varied based on the treatment area and depth of ous studies are required to fully understand the extent and dura-
penetration, with most studies noting that discomfort could be bility of these combined effects.
managed with topical analgesics or oral pain medicine [83–85].
Rare but notable adverse events include burns, scabbing, and In summary, MFU-V operates through mechanisms involving
prolonged erythema, but have been almost entirely linked to TCPs that induce collagen and elastin fiber regeneration, re-
improper device use, such as inadequate coupling between the sulting in noticeable improvements in skin structure, firmness,
transducers and patient skin [86]. Overall, proper training and and elasticity. These changes are associated with enhanced skin
device usage are critical for mitigating moderate to severe ad- quality and a reduction in skin laxity, contributing to a more re-
verse events. At the same time, pain management strategies juvenated appearance. While MFU-V demonstrates a capacity
can minimize the most frequent complications associated with to remodel the ECM and improve skin biomechanics, further
MFU-V treatment. research is needed to fully elucidate the impact and optimal
use within the field of regenerative aesthetics. Future studies
should focus on expanding patient diversity and employing ob-
8 | Limitations jective assessments to deepen our understanding of MFU-V 's
role in aesthetic medicine and its potential applications, par-
The current narrative review has several limitations. It does not ticularly when used in combination with other treatments like
represent a meta-analysis or a systematic review but rather a CaHA and HA fillers.
narrative review of scientific and clinical insights from existing
literature selected through keyword-driven searches from vari-
ous academic sources. The review examines the mechanism of Author Contributions
action and the supporting evidence for soft tissue regeneration
All authors made equally significant contributions to the concept, de-
through MFU-V without offering specific clinical practices or sign, and execution as this consensus method manuscript.
guidelines. Future meta-analyses and systematic reviews into
the efficacy of MFU-V are warranted, as are systematic reviews Acknowledgments
on adverse events. Despite these constraints, the review provides
a comprehensive overview, starting from the basic properties of The authors acknowledge Dr. Erin Scholz, an employee of Merz
Aesthetics, for her expert assistance in creating the figures for this
MFU-V to its role in enhancing soft tissue's structural and func-
manuscript. This publication was supported by Merz Aesthetics Global
tional recovery. Medical Affairs (Raleigh, NC). MERZ AESTHETICS is a trademark
and/or registered trademark of Merz Pharma GmbH & Co KGaA in
the United States and/or certain other countries; ULTHERA and
9 | Conclusions ULTHERAPY are trademarks and/or registered trademarks in the
United States and/or certain other countries. All other trademarks and/
or registered trademarks are property of their respective owners.
The presented evidence indicates that MFU-V can induce sig-
nificant changes in skin biomechanics, firmness, and elasticity,
Disclosure
suggesting its potential for regenerative effects. While studies
vary in design, including in vivo and in vitro investigations, an- Drs. Akers, Jackson, and McCarthy are employed by Merz Aesthetics
imal models, and cadaveric tissue analyses, they provide foun- (Raleigh, NC).
dational insights into MFU-V 's mechanism of action. Existing
literature outlines the generation of TCPs in the dermis, subcu- Ethics Statement
tis, and SMAS. These points induce the denaturation of colla- No human participants or animals were involved in the manuscript.
gen and supraphysiological tissue heating, initiating a biological This manuscript represents original work conducted with commitment
process that leads to the synthesis of new collagen and elastin. to ethical research practices.
The transient inflammation related to the body's healing pro-
cess results in enhanced fibroblast activity and subsequent Conflicts of Interest
ECM protein secretion, improving the structural integrity and
Dr. Vachiramon is a consultant and speaker for Merz Aesthetics,
elasticity of the skin. Beiersdorf, and L’Oreal. Dr. Pavicic is a consultant and speaker
for Merz Aesthetics and Advanced Aesthetic Technologies, and an
While the evidence is promising, there is a need for more quan- investigator for Merz Aesthetics, AbbVie, AAT, LG, and Croma.
titative basic research and randomized controlled trials with Dr. Casabona consults for Merz Aesthetics. Dr. Green speaks, ad-
standardized methodologies and objective outcome measures vises, and conducts clinical trials for Allergan Aesthetics, Croma-
to elucidate regenerative pathways and capabilities further. Pharma GmbH, Crown Pharmaceuticals, Inc., Cutera, Galderma,
L’Oreal USA, Merz Aesthetics, Revance Therapeutics, Inc., Revelle
Additionally, the current research predominantly focuses on fe-
Aesthetics, Silk Medical Aesthetics, Inc., and SkinBetter Science. Dr.
male subjects and specific ethnic groups, limiting the generaliz- Levine consults and speaks for Allergan and BTL, advises Galderma
ability of the findings, with future research needing to diversify and Merz Aesthetics, and speaks for RVL. Dr. Park consults for Merz
patient demographics to validate MFU's efficacy across different Pharmaceuticals, Allergan, and LG Chem. Dr. Spada is a consultant
populations. and speaker for Merz Aesthetics. Dr. Muniz is a medical consultant
19 of 22
14732165, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jocd.16658 by CAPES, Wiley Online Library on [27/12/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
34. A. Ghassemi, A. Prescher, D. Riediger, and H. Axer, “Anatomy of the 52. Y. Yutskovskaya, A. Sergeeva, and E. Kogan, “Combination of
SMAS Revisited,” Aesthetic Plastic Surgery 27 (2003): 258–264. Calcium Hydroxylapatite Diluted With Normal Saline and Microfocused
Ultrasound With Visualization for Skin Tightening,” Journal of Drugs in
35. S. Hu, M. Atmakuri, and J. Rosenberg, “Adverse Events of
Dermatology 19 (2020): 405–411.
Nonablative Lasers and Energy- Based Therapies in Subjects With
Fitzpatrick Skin Phototypes IV to VI: A Systematic Review and Meta- 53. D.-H. Suh, Y.-J. Oh, S.-J. Lee, et al., “A Intense-Focused Ultrasound
Analysis,” Aesthetic Surgery Journal 42 (2022): 537–547. Tightening for the Treatment of Infraorbital Laxity,” Journal of Cosmetic
and Laser Therapy 14 (2012): 290–295.
36. K. Darji, “Parallel Ultrasound Beams Versus Microfocused
Ultrasound for the Treatment of Upper Inner Arm Skin Laxity,” in 54. F. G. Lin, “Nonsurgical Treatment of Postpartum Lower Abdominal
ASLMS (Baltimore: Cadium, 2024). Skin and Soft- Tissue Laxity Using Microfocused Ultrasound With
Visualization,” Dermatologic Surgery 46 (2020): 1683–1690.
37. J.-Y. Park, F. Lin, A. Suwanchinda, et al., “Customized Treatment
Using Microfocused Ultrasound With Visualization for Optimized Patient 55. V. Vachiramon, K. Triyangkulsri, W. Iamsumang, and P.
Outcomes: A Review of Skin- Tightening Energy Technologies and a Chayavichitsilp, “Efficacy and Safety of Microfocused Ultrasound With
pan-Asian Adaptation of the Expert Panel's Gold Standard Consensus,” Visualization in Abdominal Skin Laxity: A Randomized, Comparative
Journal of Clinical and Aesthetic Dermatology 14 (2021): E70–E79. Study,” Lasers in Surgery and Medicine 52 (2020): 831–836.
38. K. Marquardt, C. Hartmann, and F. Wagner, “Microfocused 56. P. F. Meyer, M. Meleck, F. d. S. d. Borges, et al., “Effect of Microfocused
Ultrasound With Visualization Induces Remodeling of Collagen and Ultrasound on Facial Rejuvenation: Clinical and Histological Evaluation,”
Elastin Within the Skin,” Journal of Cosmetic Dermatology (2024), epub Journal of Biosciences and Medicines 9 (2021): 112–125.
ahead of print.
57. G. H. Sasaki, J. Grossman, and L. Misell. Stimulation of Collagen
39. D. H. Suh, J. H. Choi, S. J. Lee, K. H. Jeong, K. Y. Song, and M. Synthesis in Human Skin Following Ultherapy ® (Arizona, USA: ASDS
K. Shin, “Comparative Histometric Analysis of the Effects of High- Annual Meeting, 2018).
Intensity Focused Ultrasound and Radiofrequency on Skin,” Journal of
Cosmetic and Laser Therapy 17 (2015): 230–236. 58. G. Casabona, K. Kaye, S. Cotofana, K. Davidovic, M. Alfertshofer,
and L. Freytag, “Histological Effects of a Combined Collagen
40. W. M. White, I. R. S. Makin, P. G. Barthe, M. H. Slayton, and R. E. Stimulation Procedure Consisting of Microfocused Ultrasound, Soft
Gliklich, “Selective Creation of Thermal Injury Zones in the Superficial Tissue Filler, and ca-H A Injections,” Journal of Cosmetic Dermatology
Musculoaponeurotic System Using Intense Ultrasound Therapy,” 22 (2023): 1724–1730.
Archives of Facial Plastic Surgery 9 (2007): 22–29.
59. N. Krueger, S. Luebberding, M. Oltmer, M. Streker, and M. Kerscher,
41. H. N. Wilkinson and M. J. Hardman, “Wound Healing: Cellular “Age-Related Changes in Skin Mechanical Properties: A Quantitative
Mechanisms and Pathological Outcomes,” Open Biology 10 (2020): 200223. Evaluation of 120 Female Subjects,” Skin Research and Technology 17
42. G. Arango Duque and A. Descoteaux, “Macrophage Cytokines: (2011): 141–148.
Involvement in Immunity and Infectious Diseases,” Frontiers in 60. A. K. Langton, H. K. Graham, C. E. M. Griffiths, and R. E. B.
Immunology 5 (2014): 491. Watson, “Ageing Significantly Impacts the Biomechanical Function
43. V. Vachiramon, S. Rutnin, C. Patcharapojanart, and N. and Structural Composition of Skin,” Experimental Dermatology 28
Chittasirinuvat, “The Effect of Combined of Hyaluronic Acid Dermal (2019): 981–984.
Filler and Microfocused Ultrasound Treatment: A Clinicopathological 61. G. E. Piérard, S. Piérard, P. Delvenne, and C. Piérard-Franchimont,
Study,” Journal of Cosmetic Dermatology 22 (2023): 792–797. “In Vivo Evaluation of the Skin Tensile Strength by the Suction Method:
44. G. Casabona and N. Michalany, “Microfocused Ultrasound With Pilot Study Coping With Hysteresis and Creep Extension,” ISRN
Visualization and Fillers for Increased Neocollagenesis: Clinical and Dermatology 2013 (2013): 1–7.
Histological Evaluation,” Dermatologic Surgery 40 (2014): S194–S198. 62. H. P. Dobrev, “A Study of Human Skin Mechanical Properties by
45. J. N. Keagle, W. J. Welch, and D. M. Young, “Expression of Heat Shock Means of Cutometer,” Folia Medica 44 (2002): 5–10.
Proteins in a Linear Rodent Wound,” Wound Repair and Regeneration 9 63. R. Lubart and A. Lipovsky, “Immediate and Long Term Clinical
(2001): 378–385. Benefits of a Novel Topical Micronized Collagen Face Cream,” Journal of
46. B. M. Hantash, A. A. Ubeid, H. Chang, R. Kafi, and B. Cosmetics, Dermatological Sciences and Applications 12 (2022): 153–163.
Renton, “Bipolar Fractional Radiofrequency Treatment Induces 64. M. Kerscher, A. T. Nurrisyanti, C. Eiben-Nielson, S. Hartmann, and
Neoelastogenesis and Neocollagenesis,” Lasers in Surgery and J. Lambert-Baumann, “Skin Physiology and Safety of Microfocused
Medicine 41 (2009): 1–9. Ultrasound With Visualization for Improving Skin Laxity,” Clinical,
47. Y. Ishida and K. Nagata, “Hsp47 as a Collagen-Specific Molecular Cosmetic and Investigational Dermatology 12 (2019): 71–79.
Chaperone,” Methods in Enzymology 499 (2011): 167–182. 65. H. J. Lee, K. R. Lee, J. Y. Park, M. S. Yoon, and S. E. Lee, “The
48. H. J. Laubach, I. R. S. Makin, P. G. Barthe, M. H. Slayton, and D. Efficacy and Safety of Intense Focused Ultrasound in the Treatment
Manstein, “Intense Focused Ultrasound: Evaluation of a New Treatment of Enlarged Facial Pores in Asian Skin,” Journal of Dermatological
Modality for Precise Microcoagulation Within the Skin,” Dermatologic Treatment 26 (2015): 73–77.
Surgery 34 (2008): 727–734.
66. J. A. Marwick, D. A. Dorward, C. D. Lucas, et al., “Oxygen Levels
49. R. E. Gliklich, M. White, M. H. Slayton, P. G. Barthe, and I. R. Determine the Ability of Glucocorticoids to Influence Neutrophil
Makin, “Clinical Pilot Study of Intense Ultrasound Therapy to Deep Survival in Inflammatory Environments,” Journal of Leukocyte Biology
Dermal Facial Skin and Subcutaneous Tissues,” Archives of Facial 94 (2013): 1285–1292.
Plastic Surgery 9 (2007): 88–95.
67. P. P. Rovatti, G. Pellacani, and S. Guida, “Hyperdiluted Calcium
50. D. H. Suh, M. K. Shin, S. J. Lee, et al., “Intense Focused Ultrasound Hydroxylapatite 1:2 for Mid and Lower Facial Skin Rejuvenation:
Tightening in Asian Skin: Clinical and Pathologic Results,” Dermatologic Efficacy and Safety,” Dermatologic Surgery 46 (2020): e112–e117.
Surgery 37 (2011): 1595–1602.
68. A. Araco, “Prospective Study on Clinical Efficacy and Safety
51. D. H. Suh, H. J. Park, S. J. Lee, K. Y. Song, and M. K. Shin, of a Single Session of Microfocused Ultrasound With Visualization
“Superficial Intense Focused Ultrasound on Periorbital Wrinkle,” for Collagen Regeneration,” Aesthetic Surgery Journal 40 (2020):
Journal of Cosmetic and Laser Therapy 21 (2019): 412–416. 1124–1132.
21 of 22
14732165, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1111/jocd.16658 by CAPES, Wiley Online Library on [27/12/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License
101. J. Y. Park, E. J. Byun, and H. S. Kim, “Rejuvenation of Periocular
Region in Koreans: A Multimodal Approach Combining Botulinum
Toxin, Fillers, and Micro-Focused Ultrasound With Visualization for
Optimal Results,” Dermatologic Therapy 33 (2020): e13159.
102. S. Ramirez and I. B. K. Puah, “Effectiveness of Combined
Microfocused Ultrasound With Visualization and Subdermal Calcium
Hydroxyapatite Injections for the Management of Brachial Skin Laxity,”
Journal of Cosmetic Dermatology 20 (2021): 3871–3879.
103. M. Vanaman, S. G. Fabi, and S. E. Cox, “Neck Rejuvenation
Using a Combination Approach: Our Experience and a Review of the
Literature,” Dermatologic Surgery 42 (2016): S94–S100.
104. J. A. Woodward, S. G. Fabi, T. Alster, and B. Colón-Acevedo, “Safety
and Efficacy of Combining Microfocused Ultrasound With Fractional
CO2 Laser Resurfacing for Lifting and Tightening the Face and Neck,”
Dermatologic Surgery 40 (2014): S190–S193.
105. D. C. Wu, J. Karnik, T. Margarella, V. L. Nguyen, A. Calame, and M.
P. Goldman, “Evaluation of the In Vivo Effects of Various Laser, Light,
or Ultrasound Modalities on Human Skin Treated With a Collagen and
Polymethylmethacrylate Microsphere Dermal Filler Product,” Lasers in
Surgery and Medicine 48 (2016): 811–819.
106. L. A. Zaleski-Larsen, S. G. Fabi, T. McGraw, and M. Taylor, “Acne
Scar Treatment: A Multimodality Approach Tailored to Scar Type,”
Dermatologic Surgery 42 (2016): S139–S149.